Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
BIIB US
Biogen Inc.
(BIIB US)
$250.69
-3.15
1.24%
Ext:
$245.05
-5.64
2.25%
(Market Closed · 23:55:35 UTC)
Follow
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(739)
Expand
10-Q
Q2
ended 30 Jun 2026
29 Jul
8-K
Results of Operations and Financial Condition
29 Jul
8-K
Results of Operations and Financial Condition
1 Jul
8-K
Submission of Matters to a Vote of Security Holders
10 Jun
8-K/A
Financial Statements and Exhibits
10 Jun
8-K
Biogen Completes Acquisition of Apellis Pharmaceuticals
14 May
SC TO-T/A
Tender offer statement (third-party, amendment)
14 May
SC TO-T/A
AMENDMENT NO. 2
12 May
SC TO-T/A
AMENDMENT NO. 1
6 May
10-Q
Q1
ended 31 Mar 2026
29 Apr
8-K
Results of Operations and Financial Condition
29 Apr
ARS
Annual report to security holders
28 Apr
DEFA14A
Definitive additional materials
28 Apr
DEF 14A
Definitive proxy statement
28 Apr
SC TO-T
Tender offer statement (third-party)
14 Apr
SC TO-C
SCHEDULE TO
7 Apr
8-K
Results of Operations and Financial Condition
6 Apr
SC TO-C
SCHEDULE TO
3 Apr
SC TO-C
Tender offer statement (communication)
31 Mar
8-K
TENDER AND SUPPORT AGREEMENT
31 Mar
Ownership Filings
(1.9K)
Expand
4
Godbout Sean
5 Oct
4
Parini Michael
3 Sep
3
Parini Michael
12 Aug
SC 13G/A
BIOGEN INC.
6 Aug
4
Minor Lloyd
5 Aug
144
Minor Lloyd
4 Aug
144
Minor Lloyd
3 Aug
4
HAWKINS WILLIAM A
11 Jun
4
SHERWIN STEPHEN A
11 Jun
4
Rowinsky Eric K
11 Jun
4
Mantas Jesus B
11 Jun
4
LANGER SUSAN
11 Jun
4
Patolawala Monish D
11 Jun
4
Pangalos Menelas N
11 Jun
4
Minor Lloyd
11 Jun
4
Freire Maria C
11 Jun
SC 13G/A
BIOGEN INC.
5 Jun
SC 13D/A
Apellis Pharmaceuticals, Inc.
14 May
SC 13G/A
BIOGEN INC.
6 May
4
Keeney Adam
5 May
Ask in Filing